Breaking News Headlines Today

News from oncnursingnews.com

Stay current with all the latest and breaking news from oncnursingnews.com. Compare headlines and media bias behind news outlets on stories breaking today.

We’ve aggregated 185 of oncnursingnews.com’s headlines and news stories over the past 3 months.

We’ve assigned a media bias rating of unknown to oncnursingnews.com. You can read more about our methodology here.

If you want to know if oncnursingnews.com is credible or reliable, look no further. We rank oncnursingnews.com as Unknown factuality. Find out more about our methodology here.

Information about oncnursingnews.com

Where is oncnursingnews.com located?oncnursingnews.com's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

How to Give Subsequent Therapy for Older Patients With Breast Cancer on CDK4/6 Inhibitors

Treatment decisions for older adults after CDK4/6 inhibitors should be tailored, explained Courtney Moore, APRN, FNP-C, OCN.Read Article

Avutometinib/Defactinib Shows SOC Potential in LG Serous Ovarian Cancer

The addition of avutometinib to defactinib showed promising safety and efficacy for patients with low-grade serous ovarian cancer.Read Article

Mitomycin Exhibits Durable Responses in Recurrent, Low-Grade NMIBC

Adverse reactions in the phase 3 ENVISION trial were largely mild to moderate in severity, and serious reactions occurred in 12% of those with NMIBC.See the Story

How to Transition New Nurse Practitioners to Oncology

Heather Jackson, PhD, FNP-BC, NEA-BC, FAANP, explains how a fellowship program sets the tone for how to transition nurse practitioners to oncology.United States · United States Read Article

Subcutaneous Daratumumab Provides Speedier Multiple Myeloma Treatment

Subcutaneous daratumumab offers shorter clinic visits and high tolerability for patients with multiple myeloma, says Stephanie Mompoint, APRN.Read Article

Rx Road Map: Vorasidenib for the Treatment of Astrocytoma/Oligodendroglioma

This Rx Road Map outlines the most important information nurses should know when treating patients with astrocytoma or oligodendroglioma with vorasidenib.Healthcare Read Article

Oncology Nurse Inclusion Is Crucial to Stepwise Opioid Reduction Model

Ronald Bleday, MD, explained that a model to reduce opioid use in patients after colorectal surgery relies on nurses familiar with the relevant surgeries.Maryland · Maryland Read Article

Supporting Patients Through Treatment for Advanced NSCLC

Panelists discuss how dose modifications for ALK inhibitors can significantly improve quality of life issues like brain fog and weight gain while maintaining disease control, emphasizing the importance of multidisciplinary team support including palliative care from diagnosis.United States · United States See the Story

Future Outlooks and Next Steps in Later R/R MM

Panelists discuss that shifting talquetamab dosing from weekly to every 2 weeks improves response durability and patient quality of life, while emphasizing that temporary treatment holds due to adverse effects are manageable, and ongoing research is vital to address unmet needs and advance multiple myeloma care.United States · United States Read Article

News from oncnursingnews.com